SAN CLEMENTE, Calif., Aug. 29, 2011 (GLOBE NEWSWIRE) -- ICU Medical, Inc., (Nasdaq:ICUI), a leader in innovative products used in vascular therapy, oncology and critical care applications, today announced that Company management will present at the following two investor conferences:
- The Rodman & Renshaw 13th Annual Healthcare Conference to be held on September 11-13 at The Waldorf=Astoria Hotel in New York. The presentation will take place on Tuesday, September 13, at 2:25 PM Eastern Time.
The presentation will be webcast live and can be accessed by going to the Company's website at http://www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
- The UBS Global Life Sciences Conference 2011 to be held on September 19-21 at the Grand Hyatt New York in New York. The presentation will take place on Wednesday, September 21, at 1:30 PM Eastern Time.
The presentation will be broadcast live and can be accessed by going to the UBS Investment Bank website at http://www.ibb.ubs.com. A copy of the slides to be presented may be found by going to the Company's website at http://www.icumed.com, clicking on the Investors tab, clicking on Presentations and clicking on the September 2011 Investor Presentation.
About ICU Medical, Inc.
ICU Medical, Inc. develops, manufactures and sells innovative medical technologies used in vascular therapy, oncology, and critical care applications. ICU Medical's products improve patient outcomes by helping prevent bloodstream infections, protect healthcare workers and patients from exposure to infectious diseases or hazardous drugs, and monitor the hemodynamic status of critical care patients. The company's complete product line includes custom I.V. systems, closed delivery systems for hazardous drugs, needleless I.V. connectors, catheters and cardiac monitoring systems. ICU Medical is headquartered in San Clemente, California. For more information, visit www.icumed.com.